These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 16034894)

  • 1. Cellulose, modified cellulose and synthetic membranes in the haemodialysis of patients with end-stage renal disease.
    Macleod AM; Campbell M; Cody JD; Daly C; Donaldson C; Grant A; Khan I; Rabindranath KS; Vale L; Wallace S
    Cochrane Database Syst Rev; 2005 Jul; 2005(3):CD003234. PubMed ID: 16034894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of cellulose, modified cellulose and synthetic membranes in the haemodialysis of patients with end-stage renal disease.
    MacLeod A; Daly C; Khan I; Vale L; Campbell M; Wallace S; Cody J; Donaldson C; Grant A
    Cochrane Database Syst Rev; 2001; (3):CD003234. PubMed ID: 11687058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency of administration of recombinant human erythropoietin for anaemia of end-stage renal disease in dialysis patients.
    Cody J; Daly C; Campbell M; Donaldson C; Grant A; Khan I; Vale L; Wallace S; MacLeod A
    Cochrane Database Syst Rev; 2002; (4):CD003895. PubMed ID: 12519614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuous ambulatory peritoneal dialysis (CAPD) versus hospital or home haemodialysis for end-stage renal disease in adults.
    Vale L; Cody J; Wallace S; Daly C; Campbell M; Grant A; Khan I; Donaldson C; Macleod A
    Cochrane Database Syst Rev; 2004 Oct; 2004(4):CD003963. PubMed ID: 15495072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant human erythropoietin for chronic renal failure anaemia in pre-dialysis patients.
    Cody J; Daly C; Campbell M; Donaldson C; Grant A; Khan I; Pennington S; Vale L; Wallace S; MacLeod A
    Cochrane Database Syst Rev; 2001; (4):CD003266. PubMed ID: 11687180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequency of administration of recombinant human erythropoietin for anaemia of end-stage renal disease in dialysis patients.
    Cody J; Daly C; Campbell M; Donaldson C; Khan I; Vale L; Wallace S; Macleod A
    Cochrane Database Syst Rev; 2005 Jul; (3):CD003895. PubMed ID: 16034913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-flux versus low-flux membranes for end-stage kidney disease.
    Palmer SC; Rabindranath KS; Craig JC; Roderick PJ; Locatelli F; Strippoli GF
    Cochrane Database Syst Rev; 2012 Sep; 2012(9):CD005016. PubMed ID: 22972082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuous ambulatory peritoneal dialysis (CAPD) versus hospital or home haemodialysis for end-stage renal disease in adults.
    Vale L; Cody J; Wallace S; Daly C; Campbell M; Grant A; Khan I; Donaldson C; MacLeod A
    Cochrane Database Syst Rev; 2003; (1):CD003963. PubMed ID: 12535493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Barrier agents for adhesion prevention after gynaecological surgery.
    Ahmad G; Kim K; Thompson M; Agarwal P; O'Flynn H; Hindocha A; Watson A
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD000475. PubMed ID: 32199406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychosocial interventions for preventing and treating depression in dialysis patients.
    Natale P; Palmer SC; Ruospo M; Saglimbene VM; Rabindranath KS; Strippoli GF
    Cochrane Database Syst Rev; 2019 Dec; 12(12):CD004542. PubMed ID: 31789430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of hemodialysis, hemofiltration, and acetate-free biofiltration for ESRD: systematic review.
    Rabindranath KS; Strippoli GF; Roderick P; Wallace SA; MacLeod AM; Daly C
    Am J Kidney Dis; 2005 Mar; 45(3):437-47. PubMed ID: 15754266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant human erythropoietin for chronic renal failure anaemia in pre-dialysis patients.
    Cody J; Daly C; Campbell M; Donaldson C; Khan I; Rabindranath K; Vale L; Wallace S; Macleod A
    Cochrane Database Syst Rev; 2005 Jul; (3):CD003266. PubMed ID: 16034896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuous ambulatory peritoneal dialysis versus automated peritoneal dialysis for end-stage renal disease.
    Rabindranath KS; Adams J; Ali TZ; MacLeod AM; Vale L; Cody J; Wallace SA; Daly C
    Cochrane Database Syst Rev; 2007 Apr; 2007(2):CD006515. PubMed ID: 17443624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. β-trace protein is highly removed during haemodialysis with high-flux and super high-flux membranes.
    Donadio C; Tognotti D; Caponi L; Paolicchi A
    BMC Nephrol; 2017 Feb; 18(1):68. PubMed ID: 28219328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biocompatible hemodialysis membranes for acute renal failure.
    Alonso A; Lau J; Jaber BL
    Cochrane Database Syst Rev; 2008 Jan; 2008(1):CD005283. PubMed ID: 18254074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haemodiafiltration, haemofiltration and haemodialysis for end-stage kidney disease.
    Rabindranath KS; Strippoli GF; Daly C; Roderick PJ; Wallace S; MacLeod AM
    Cochrane Database Syst Rev; 2006 Oct; (4):CD006258. PubMed ID: 17054289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HMG CoA reductase inhibitors (statins) for dialysis patients.
    Navaneethan SD; Nigwekar SU; Perkovic V; Johnson DW; Craig JC; Strippoli GF
    Cochrane Database Syst Rev; 2009 Apr; (2):CD004289. PubMed ID: 19370598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biocompatible hemodialysis membranes for acute renal failure.
    Alonso A; Lau J; Jaber BL
    Cochrane Database Syst Rev; 2005 Apr; (2):CD005283. PubMed ID: 15846749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic reviews of the effectiveness of day care for people with severe mental disorders: (1) acute day hospital versus admission; (2) vocational rehabilitation; (3) day hospital versus outpatient care.
    Marshall M; Crowther R; Almaraz-Serrano A; Creed F; Sledge W; Kluiter H; Roberts C; Hill E; Wiersma D; Bond GR; Huxley P; Tyrer P
    Health Technol Assess; 2001; 5(21):1-75. PubMed ID: 11532238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HMG CoA reductase inhibitors (statins) for dialysis patients.
    Navaneethan SD; Nigwekar SU; Perkovic V; Johnson DW; Craig JC; Strippoli GF
    Cochrane Database Syst Rev; 2009 Jul; (3):CD004289. PubMed ID: 19588351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.